Fluicell AB (OSTO:FLUI) Ending Cash Position: kr1.30 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:FLUI Fluicell AB OSTO:FLUI
54 GF Score
Price kr29.50
GF Value kr33.88
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fluicell AB Ending Cash Position?

Fluicell AB OSTO:FLUI -3.28% 54 Ending Cash Position is kr1.30 Mil as of Mar. 2026. GuruFocus rates OSTO:FLUI with a GF Score™ of 54/100 and a GF Value™ of kr33.88 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Fluicell AB's Ending Cash Position for the quarter that ended in Mar. 2026 was kr1.30 Mil.

Fluicell AB's quarterly Ending Cash Position increased from Sep. 2025 (kr0.99 Mil) to Dec. 2025 (kr2.26 Mil) but then declined from Dec. 2025 (kr2.26 Mil) to Mar. 2026 (kr1.30 Mil).

Fluicell AB's annual Ending Cash Position increased from Dec. 2023 (kr2.76 Mil) to Dec. 2024 (kr15.92 Mil) but then declined from Dec. 2024 (kr15.92 Mil) to Dec. 2025 (kr2.26 Mil).

Fluicell AB Ending Cash Position Related Terms

Fluicell AB Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Fluicell AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fluicell AB Ending Cash Position Chart

Fluicell AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.69 24.46 2.76 15.92 2.26

Fluicell AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.71 4.50 0.99 2.26 1.30
OSTO:FLUI
54GF Score
Fluicell AB OSTO:FLUI
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fluicell AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Fluicell AB's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=15.924+-13.662
=2.26

Fluicell AB's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.262+-0.965
=1.30

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of kr1.30 Mil mean?
Fluicell AB (OSTO:FLUI) has a Ending Cash Position of kr1.30 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Fluicell AB and its competitors.
Is Fluicell AB's Ending Cash Position too high?
Fluicell AB's current Ending Cash Position is kr1.30 Mil. Overall, Fluicell AB has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fluicell AB's Ending Cash Position compare to VRTX and REGN?
Fluicell AB's Ending Cash Position of kr1.30 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Fluicell AB and its competitors. Fluicell AB's current Ending Cash Position is kr1.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fluicell AB stock overvalued right now?
Based on GuruFocus' analysis, Fluicell AB (OSTO:FLUI) is currently considered Modestly Undervalued. The stock's GF Value™ is kr33.88, compared to a current price of kr29.50 — trading 12.9% below its estimated fair value. The current Ending Cash Position is kr1.30 Mil. Fluicell AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Fluicell AB (OSTO:FLUI), the current Ending Cash Position is kr1.30 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fluicell AB (OSTO:FLUI) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be undervalued. The current stock price of kr29.50 is trading 12.9% below its estimated GF Value™ of kr33.88. GuruFocus considers Fluicell AB to be Modestly Undervalued.

Key valuation signals for OSTO:FLUI:

  • Ending Cash Position: kr1.30 Mil
  • GF Value™: kr33.88 vs. price of kr29.50 (12.9% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:FLUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Other Exchanges 5J90:Germany
Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
54GF Score

Get the complete analysis for OSTO:FLUI

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr29.50
Price
kr33.88
GF Value